全文获取类型
收费全文 | 616篇 |
免费 | 50篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 39篇 |
妇产科学 | 15篇 |
基础医学 | 107篇 |
口腔科学 | 45篇 |
临床医学 | 44篇 |
内科学 | 114篇 |
皮肤病学 | 4篇 |
神经病学 | 54篇 |
特种医学 | 12篇 |
外科学 | 40篇 |
一般理论 | 1篇 |
预防医学 | 48篇 |
眼科学 | 16篇 |
药学 | 75篇 |
肿瘤学 | 46篇 |
出版年
2024年 | 3篇 |
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 12篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 11篇 |
2017年 | 24篇 |
2016年 | 17篇 |
2015年 | 17篇 |
2014年 | 27篇 |
2013年 | 32篇 |
2012年 | 49篇 |
2011年 | 39篇 |
2010年 | 23篇 |
2009年 | 39篇 |
2008年 | 42篇 |
2007年 | 28篇 |
2006年 | 31篇 |
2005年 | 33篇 |
2004年 | 43篇 |
2003年 | 32篇 |
2002年 | 36篇 |
2001年 | 7篇 |
2000年 | 2篇 |
1999年 | 9篇 |
1998年 | 9篇 |
1997年 | 10篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 12篇 |
1993年 | 3篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 1篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1974年 | 1篇 |
1960年 | 1篇 |
1947年 | 2篇 |
排序方式: 共有672条查询结果,搜索用时 67 毫秒
1.
2.
The World Health Report 2000 on health systems has raised concerns about its political biases, its methods and indicators, and its lack of reliable data. Tracing the origins of the Report, this article argues that it counteracts many of the concerns that gave rise to preparation of the Report in the first place. The mutually agreed-upon value-base, expressed in the Health for All strategy, has been largely abandoned. The Report includes contradictory messages, and many of its recommendations are not evidence-based. Furthermore, the ranking of countries according to their health systems' performance is not useful for health-policy-making, even if the methods and data could be improved. Because the member states and governing bodies of the WHO were not consulted during the production of the Report, the WHO secretariat has not received a mandate to change the value-base of the WHO's health policy or the aims of the Report. The WHO should return to its mandate as a normative intergovernmental U.N. agency on health. 相似文献
3.
Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice. 总被引:2,自引:0,他引:2
Eeva K Broberg Niko Set?l? Juha-Pekka Er?linna Aimo A Salmi Matias R?ytt? Veijo Hukkanen 《Journal of interferon & cytokine research》2002,22(6):641-651
We investigated the expression kinetics of several cytokines in trigeminal ganglia (TG) and in brains of BALB/c mice during the course of ocular herpes simplex virus type 1 (HSV-1) infection. All mice recovered from the infection within 2 weeks. The quantitative rapid real-time RT-PCR method was used to analyze interleukin-4 (IL-4), interferon-gamma (IFN-gamma), IL-12p35, IL-12p40, and the recently described IL-23 (p19) mRNA in TG, brain, and splenocyte samples. In TG, we found elevated expression of mRNA for IL-23 (p19) from early acute infection (day 3) to the beginning of the latent phase (day 14). The increase was not detected in brain or in the spleen. IL-4 expression occurred in both TG and brain from the beginning of the experiment to the latent phase. During the latent phase (days 14 and 31), IL-4 expression was significantly elevated in the brain when compared with the uninfected controls (p < 0.05). Considerable expression of IFN-gamma mRNA was detected in TG of mice during acute HSV-1 infection. The expression of IL-23 was detected also in the brains of the mice, even though no significant changes were found during the acute HSV-1 infection. This is, to our knowledge, the first report to show elevated expression of IL-23 (p19) mRNA (p < 0.05) during viral infection in TG of mice. 相似文献
4.
Eeva Ollila 《Globalization and health》2005,1(1):6
Health has gained importance on the global agenda. It has become recognized in forums where it was once not addressed. In
this article three issues are considered: global health policy actors, global health priorities and the means of addressing
the identified health priorities. I argue that the arenas for global health policy-making have shifted from the public spheres
towards arenas that include the transnational for-profit sector. Global health policy has become increasingly fragmented and
verticalized. Infectious diseases have gained ground as global health priorities, while non-communicable diseases and the
broader issues of health systems development have been neglected. Approaches to tackling the health problems are increasingly
influenced by trade and industrial interests with the emphasis on technological solutions. 相似文献
5.
Eray M Postila V Eeva J Ripatti A Karjalainen-Lindsberg ML Knuutila S Andersson LC Pelkonen J 《Scandinavian journal of immunology》2003,57(6):545-555
In the periphery, B cells differentiate in germinal centres (GCs) of secondary lymphoid organs. Isolated GC cells die quickly in vitro by apoptosis. Therefore, cell lines originating from follicular lymphomas, which are the malignant counterparts of GC B cells, would provide a stable in vitro model to study the immunobiology of GC B cells. We have established three novel human follicular lymphoma cell lines that were characterized with special reference to immunophenotypic features, response to B-cell receptor (BCR) triggering, response to cytokines and cytokine mRNA expression. One of the cell lines, HF-1A3, has a phenotype of a centrocyte. It expresses surface immunoglobulin G (sIgG) and dies by apoptosis following BCR cross-linking. Co-stimulation with interleukin-6 (IL-6), IL-15 or interferon-gamma (IFN-gamma) rescues HF-1A3 cells from BCR-induced apoptosis. The second cell line, HF-28, also represents phenotypically an IgG+ centrocyte. Ligation of its BCR leads to the cell-cycle arrest at G1 instead of apoptosis. HF-28 cells express both CD45RA and RO isoforms, which is unusual in B lymphocytes apart from plasma cells, thus suggesting a transition to plasma cell phenotype. The third cell line, HF-4.9, which phenotypically represents an sIgM+ centroblast, responds by proliferation to BCR cross-linking. These cell lines offer a unique in vitro model to study antigenic selection and cytokine-mediated growth regulation of human GC B cells. 相似文献
6.
Laurila E Syrjäkoski K Holli K Kallioniemi A Karhu R 《Cancer Genetics and Cytogenetics》2005,163(1):57-61
Mutations in the BRCA1 and BRCA2 genes are known to predispose to breast cancer. In Finland, however, only 21% of all breast cancer families have mutations in these genes. Recent studies have shown that large genomic alterations of BRCA1 are common in many countries. Because such alterations will be missed in conventional mutation screening strategies, we decided to screen Finnish breast and ovarian cancer families for genomic alterations by using a multiplex polymerase chain reaction method. The most characteristic features of BRCA1-related breast cancer were used to select patients, namely (1) both breast and ovarian cancer in the family (48 patients), (2) four or more breast cancers in family (22 patients), or (3) young age (< or =40 years) of onset (58 patients). A total of 128 patients were included in the study. All exons of BRCA1 were analyzed but no alterations were found. This study excludes the frequent occurrence of large genomic alterations in the BRCA1 gene in Finland. Here, again, Finland differs from other countries with a mixed population structure. Our results are in agreement with the common hypothesis that there are still unknown breast cancer susceptibility gene(s) that are responsible for breast cancer predisposition. 相似文献
7.
8.
9.
Testing for high‐risk HPV in cervical and tonsillar paraffin‐embedded tissue using a cartridge‐based assay 下载免费PDF全文
Elina Virtanen Pekka Laurila Jaana Hagström Pekka Nieminen Eeva Auvinen 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2017,125(10):910-915
This study evaluates the suitability of Xpert HPV (Cepheid, Sunnyvale, CA, USA) test for cervical and tonsillar formalin‐fixed paraffin‐embedded (FFPE) tissue samples as compared to the tests currently used in diagnostics. Cervical biopsies and liquid cytology (LC) samples were collected from 48 women attending colposcopy. Biopsies were processed for histology and tested for hrHPV using Xpert HPV. LC samples were tested using Xpert and Hybrid Capture 2 (HC2; Qiagen, Hilden, Germany) tests. Also 29 archived tonsillar carcinoma samples were tested using Xpert, and the results were compared with histology and immunohistochemical p16INK4a (p16) staining. Among valid cervical LC samples 46.8% were hrHPV positive using Xpert test and 55.3% with HC2. The sensitivity of Xpert was 84.6% as compared to HC2, and overall test concordance was 91.5%. Test concordance between valid Xpert results from biopsies and LC samples was 84.6%. Among valid tonsillar samples 70.4% were hrHPV positive, and concordance of 96.3% was found between Xpert and p16 staining. To conclude, Xpert HPV test cartridge provides a convenient platform to test individual samples, including FFPE samples. Further studies are needed to establish whether test sensitivity is sufficient to reliably differentiate between hrHPV positive and hrHPV negative head and neck carcinomas. 相似文献
10.